Ilic G, Karadzic R, Kostic-Banovic L, Stojanovic J, Antovic A
Bosn J Basic Med Sci. 2010; 10(1):38-43.
PMID: 20192929
PMC: 5596609.
DOI: 10.17305/bjbms.2010.2730.
Campana C, Regazzi M, Buggia I, Molinaro M
Clin Pharmacokinet. 1996; 30(2):141-79.
PMID: 8906896
DOI: 10.2165/00003088-199630020-00004.
Strolin Benedetti M, Dostert P
Environ Health Perspect. 1994; 102 Suppl 9:101-5.
PMID: 7698069
PMC: 1566786.
DOI: 10.1289/ehp.94102s9101.
Colmenero J, Agundez J, Sedeno J, Benitez J, Valverde E
Antimicrob Agents Chemother. 1994; 38(12):2798-802.
PMID: 7695265
PMC: 188288.
DOI: 10.1128/AAC.38.12.2798.
Galeazzi R, Lorenzini I, Orlandi F
Dig Dis Sci. 1980; 25(2):108-12.
PMID: 7353456
DOI: 10.1007/BF01308307.
Hepatocyte localization of hepatitis B core and surface antigens in renal transplant recipients. An ultrastructural prospective study.
Amat D, Camilleri J, Feldmann G, Bloch F, Duboust A, Bedrossian J
Virchows Arch A Pathol Anat Histol. 1981; 391(2):153-63.
PMID: 7013255
DOI: 10.1007/BF00437593.
Rifampicin reduces effectiveness and bioavailability of prednisolone.
McAllister W, Thompson P, Rogers H
Br Med J (Clin Res Ed). 1983; 286(6369):923-5.
PMID: 6403136
PMC: 1547305.
DOI: 10.1136/bmj.286.6369.923.
In vitro interactions between rifampin and ampicillin or chloramphenicol against Haemophilus influenzae.
Jadavji T, Prober C, Cheung R
Antimicrob Agents Chemother. 1984; 26(1):91-3.
PMID: 6332573
PMC: 179924.
DOI: 10.1128/AAC.26.1.91.
[Postmortem evaluation of barbiturate poisonings].
Schmoldt A, Beckmann E, Horstmann W
Z Rechtsmed. 1984; 93(1):33-41.
PMID: 6149661
DOI: 10.1007/BF00202982.
Clinical implications of enzyme induction and enzyme inhibition.
Park B, Breckenridge A
Clin Pharmacokinet. 1981; 6(1):1-24.
PMID: 6113907
DOI: 10.2165/00003088-198106010-00001.
Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease.
Acocella G, BONOLLO L, GARIMOLDI M, Mainardi M, TENCONI L, NICOLIS F
Gut. 1972; 13(1):47-53.
PMID: 5060669
PMC: 1411976.
DOI: 10.1136/gut.13.1.47.
Serum concentration and half-life of rifampicin after simultaneous oral administration of aminosalicylic acid or isoniazid.
Boman G
Eur J Clin Pharmacol. 1974; 7(3):217-25.
PMID: 4854257
DOI: 10.1007/BF00560384.
Enzyme induction and man.
Hunter J
Ir J Med Sci. 1974; 0(0):suppl:85-92.
PMID: 4851878
DOI: 10.1007/BF02938130.
Enzyme induction and medical treatment.
Hunter J
J R Coll Physicians Lond. 1974; 8(2):163-74.
PMID: 4810112
PMC: 5366562.
A morphometric study of the endoplasmic reticulum in human hepatocytes. Correlation between morphological and biochemical data in subjects under treatment with certain drugs.
JEZEQUEL A, Koch M, Orlandi F
Gut. 1974; 15(9):737-47.
PMID: 4435590
PMC: 1413036.
DOI: 10.1136/gut.15.9.737.
A case of variant angina exacerbated by administration of rifampicin.
Tsuchihashi K, Fukami K, Kishimoto H, Sumiyoshi T, Haze K, Saito M
Heart Vessels. 1987; 3(4):214-7.
PMID: 3453828
DOI: 10.1007/BF02058314.
Multiple-dose pharmacokinetics of concurrent oral ciprofloxacin and rifampin therapy in elderly patients.
CHANDLER M, Toler S, Rapp R, Muder R, Korvick J
Antimicrob Agents Chemother. 1990; 34(3):442-7.
PMID: 2185691
PMC: 171612.
DOI: 10.1128/AAC.34.3.442.
Pharmacokinetic drug interactions with rifampicin.
Venkatesan K
Clin Pharmacokinet. 1992; 22(1):47-65.
PMID: 1559307
DOI: 10.2165/00003088-199222010-00005.
Two- and four-day rifampin chemoprophylaxis regimens induce oxidative metabolism.
Borcherding S, Bastian T, Self T, LeDuc B, Lalonde R
Antimicrob Agents Chemother. 1992; 36(7):1553-8.
PMID: 1510454
PMC: 191619.
DOI: 10.1128/AAC.36.7.1553.
Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.
Zilly W, Breimer D, Richter E
Eur J Clin Pharmacol. 1975; 9(2-3):219-27.
PMID: 1233266
DOI: 10.1007/BF00614021.